Surgical management of inflammatory bowel disease

M E Ba'ath1, M W Mahmalat, P Kapur

  • 1Department of Paediatric Surgery, Royal Liverpool Children's Hospital NHS Trust, Liverpool, UK.

Insights

Surgical outcomes for pediatric inflammatory bowel disease (IBD) show limited resection is safe for Crohn's disease proximal to the left colon. For disease distal to the transverse colon, subtotal colectomy is preferred over anastomosis.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Inflammatory Bowel Disease Research

Background:

  • Inflammatory bowel disease (IBD) in children often necessitates surgical intervention.
  • Evaluating surgical outcomes and morbidity is crucial for optimizing treatment strategies in pediatric IBD patients.

Purpose of the Study:

  • To assess the outcomes and complication rates associated with major surgical procedures for pediatric inflammatory bowel disease (IBD).
  • To determine the safety and efficacy of different surgical approaches for Crohn's disease and ulcerative colitis in children.

Main Methods:

  • Retrospective analysis of 227 pediatric IBD cases treated between 1994 and 2002.
  • Review of surgical interventions, including resections, anastomoses, and reconstructions, and their associated morbidities.

Main Results:

  • For Crohn's disease, 21% of patients required surgery. Limited resection with primary anastomosis was safe for disease proximal to the left colon (0% morbidity). However, conservative segmental resections for disease distal to the transverse colon had a 100% complication rate.
  • For ulcerative colitis, 22% of patients underwent surgery. J-pouch ileoanal anastomosis yielded good functional outcomes (continence in 10/11 children). Straight ileoanal anastomosis resulted in unacceptable stool frequency in all patients.
  • Overall complication rates were 57% for Crohn's disease surgery and 31% for ulcerative colitis surgery.

Conclusions:

  • Limited segmental resection with primary anastomosis is a safe and effective surgical option for pediatric Crohn's disease proximal to the left colon.
  • For pediatric Crohn's disease distal to the transverse colon, subtotal or panproctocolectomy is recommended, avoiding anastomosis due to high complication rates.
  • J-pouch reconstruction offers good functional outcomes for pediatric ulcerative colitis, while straight ileoanal anastomosis has a high failure rate.
Abstract

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...